Notifications
Clear all
Peptide Therapy
2
Posts
2
Users
0
Reactions
50
Views
Topic starter
07/09/2026 3:02 pm
Translate
â–¼
English
Spanish
French
German
Italian
Portuguese
Russian
Chinese
Japanese
Korean
Arabic
Hindi
Dutch
Polish
Turkish
Vietnamese
Thai
Swedish
Danish
Finnish
Norwegian
Czech
Hungarian
Romanian
Greek
Hebrew
Indonesian
Malay
Ukrainian
Bulgarian
Croatian
Slovak
Slovenian
Serbian
Lithuanian
Latvian
Estonian
... peptide inhibitors that bind simultaneously to penicillin-binding proteins PBP2b and PBP2x, the two primary resistance determinants in pneumococci.
https://bioengineer.org/novel-peptides-designed-to-block-drug-resistant-pneumonia-bacteria-targets/
Translate
â–¼
English
Spanish
French
German
Italian
Portuguese
Russian
Chinese
Japanese
Korean
Arabic
Hindi
Dutch
Polish
Turkish
Vietnamese
Thai
Swedish
Danish
Finnish
Norwegian
Czech
Hungarian
Romanian
Greek
Hebrew
Indonesian
Malay
Ukrainian
Bulgarian
Croatian
Slovak
Slovenian
Serbian
Lithuanian
Latvian
Estonian
The idea of targeting both PBP2b and PBP2x is interesting. Since these proteins are involved in antibiotic resistance in pneumococci, it will be important to see how these peptides perform in further laboratory and clinical research.
Leave a reply